Literature DB >> 31407386

Higher thyroid-stimulating hormone levels in the first trimester are associated with gestational diabetes in a Chinese population.

J Leng1, W Li1, L Wang1, S Zhang1, H Liu1, W Li1, S Wang1, P Shao1, L Pan1, S Wang1, E Liu1.   

Abstract

AIM: To evaluate the relationship between maternal thyroid-stimulating hormone levels during the first trimester and gestational diabetes risk.
METHODS: In Tianjin, China, 7258 women underwent a thyroid-stimulating hormone screening test within 12 gestational weeks and then had a glucose challenge test at 24-28 weeks of gestational age. The women with a glucose challenge test ≥7.8 mmol/l underwent a 75 g oral glucose tolerance test. Gestational diabetes was diagnosed following International Association of Diabetes and Pregnancy Study Group criteria. Restricted cubic spline analysis was performed to explore full-range risk associations of thyroid-stimulating hormone levels with gestational diabetes. Logistic regression was performed to obtain odds ratios and 95% confidence intervals.
RESULTS: In all, 594 women (8.2%) had gestational diabetes. Among women with thyroid-stimulating hormone ≤3.2 mIU/l, a positive association between thyroid-stimulating hormone levels and gestational diabetes risk was found (adjusted OR: 1.13, 95% CI: 1.00-1.27). There was no relationship between thyroid-stimulating hormone levels and gestational diabetes risk in univariable and multivariable analyses among women with thyroid-stimulating hormone >3.2 mIU/l. In subgroup analyses, among women with thyroid-stimulating hormone ≤3.2 mIU/l and BMI ≥25 kg/m2 , the adjusted odds ratio for thyroid-stimulating hormone levels with gestational diabetes was enhanced to 1.25 (95% CI: 1.02-1.53).
CONCLUSIONS: In pregnant Chinese women, thyroid-stimulating hormone levels even within normal range in the first trimester were positively related to gestational diabetes risk, especially for pre-pregnancy overweight/obese women.
© 2019 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31407386     DOI: 10.1111/dme.14106

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  4 in total

Review 1.  A pathway level analysis of PFAS exposure and risk of gestational diabetes mellitus.

Authors:  Rahel L Birru; Hai-Wei Liang; Fouzia Farooq; Megha Bedi; Maisa Feghali; Catherine L Haggerty; Dara D Mendez; Janet M Catov; Carla A Ng; Jennifer J Adibi
Journal:  Environ Health       Date:  2021-05-22       Impact factor: 7.123

2.  Associations between thyroid function and gestational diabetes mellitus in Chinese pregnant women: a retrospective cohort study.

Authors:  Geng-Dong Chen; Xiao-Yan Gou; Ting-Ting Pang; Peng-Sheng Li; Zi-Xing Zhou; Dong-Xin Lin; Da-Zhi Fan; Xiao-Ling Guo; Li-Juan Wang; Zheng-Ping Liu
Journal:  BMC Endocr Disord       Date:  2022-02-21       Impact factor: 2.763

3.  Higher Thyroid fT3-to-fT4 Ratio Is Associated with Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes.

Authors:  Lore Raets; Caro Minschart; Annick Van den Bruel; Emmelien Van den Bogaert; Paul Van Crombrugge; Carolien Moyson; Johan Verhaeghe; Sofie Vandeginste; Hilde Verlaenen; Chris Vercammen; Toon Maes; Els Dufraimont; Nele Roggen; Christophe De Block; Yves Jacquemyn; Farah Mekahli; Katrien De Clippel; Anne Loccufier; Annouschka Laenen; Roland Devlieger; Chantal Mathieu; Brigitte Decallonne; Katrien Benhalima
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

4.  Incidence and Risk Factors of Gestational Diabetes Mellitus: A Prospective Cohort Study in Qingdao, China.

Authors:  Guoju Li; Tao Wei; Wei Ni; Ai Zhang; Jun Zhang; Yuhan Xing; Quansheng Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-11       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.